Understanding this nuanced risk-benefit profile enables informed shared decision-making between healthcare providers and patients considering GLP-1 therapy
Our mass tort attorneys at Boesen Law are reviewing claims from patients who developed bowel obstruction after using brand-name GLP-1 medications such as Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound
Related Stories Researchers propose new framework to define clinical obesity Endotrophin may reveal metabolic risks linked to changing body fat Generic semaglutide could improve diabetes treatment affordability in Canada Retatrutide treatment also led to changes in branched-chain amino acids (BCAAs) and their catabolic products linked to insulin resistance
Before she started taking the medication, she felt overwhelmed by a sense of apathy that kept her from exercising and staying active, she says
The reconstituted solution at standard 3mL BAC water gives ~16.67mg/mL BPC-157 and ~3.33mg/mL each of TB-500, KPV, and GHK-Cu
Involvement of the basal anteroseptal wall is characteristic